BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1830674)

  • 1. [Conservative therapy of parenchymal renal carcinoma].
    Graziotti P; Romano C; Belussi D; Guizzetti C; Ranieri A; Giannone V; Tura M; Hurle R; Losa A; Monticelli L
    Arch Ital Urol Nefrol Androl; 1991 Jun; 63(2):253-6. PubMed ID: 1830674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma.
    Blute ML; Itano NB; Cheville JC; Weaver AL; Lohse CM; Zincke H
    J Urol; 2003 Apr; 169(4):1276-81. PubMed ID: 12629342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parenchyma-conserving surgery for renal cell carcinoma.
    Taari K; Salo JO; Rannikko S; Kärkkäinen P; Nordling S; Lehtonen T
    Ann Chir Gynaecol Suppl; 1993; 206():54-8. PubMed ID: 8291871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The surgical treatment and prognosis of bilateral sporadic renal tumors].
    Zhang N; Gong K; Zhou LQ; Yang Y; Na YQ
    Zhonghua Wai Ke Za Zhi; 2007 Jan; 45(2):121-3. PubMed ID: 17418042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
    Yoo C; Song C; Hong JH; Kim CS; Ahn H
    J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: Long-term survival data of 216 patients.
    Becker F; Siemer S; Humke U; Hack M; Ziegler M; Stöckle M
    Eur Urol; 2006 Feb; 49(2):308-13. PubMed ID: 16359779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Partial kidney resection in renal cell carcinoma].
    Danuser H; Studer UE; Zingg EJ
    Schweiz Med Wochenschr; 1993 Jul; 123(26):1337-43. PubMed ID: 8342002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Conservative surgery for renal carcinoma].
    González Martín M; Alvarez Castelo LM; Chantada Abal V; Rodríguez-Rivera J; Sánchez Merino JM; Gómez Veiga F
    Actas Urol Esp; 1999 May; 23(5):424-31. PubMed ID: 10427817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral synchronous sporadic renal cell carcinoma: surgical management, oncological and functional outcomes.
    Pahernik S; Cudovic D; Roos F; Melchior SW; Thüroff JW
    BJU Int; 2007 Jul; 100(1):26-9. PubMed ID: 17552949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephron sparing surgery for central renal tumors: experience with 33 cases.
    Black P; Filipas D; Fichtner J; Hohenfellner R; Thüroff JW
    J Urol; 2000 Mar; 163(3):737-43. PubMed ID: 10687967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nephron-sparing surgery for localized kidney neoplasms--a report of 25 cases].
    Li YH; Zhou FJ; Qin ZK; Han H; Liu ZW; Wang B; Yu SL; Wang H
    Ai Zheng; 2006 Jan; 25(1):76-9. PubMed ID: 16405755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nephron-sparing surgery for small renal cell carcinoma: clinical analysis of 21 cases].
    Xiao YJ; Zheng SB; Tan WL; Chen T; Qi H; Shao ZQ; Jiang YD; Wu P; Zhang HJ
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Mar; 25(3):357-9. PubMed ID: 15772014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bilateral asynchronous renal cell carcinoma: treatment approach.
    Kessler OJ; Livne PM; Servadio C
    Isr J Med Sci; 1993 Nov; 29(11):721-5. PubMed ID: 8270406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of von Hippel-Lindau disease with renal involvement].
    Chrétien Y; Chauveau D; Richard S; Droz D; Correas JM; Mejean A; Dufour B; Grünfeld JP
    Prog Urol; 1997 Dec; 7(6):939-47. PubMed ID: 9490138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Local recurrence after organ saving kidney tumor surgery].
    Brkovic D; Riedasch G; Waldherr R; Röhl L; Staehler G
    Urologe A; 1994 Mar; 33(2):104-9. PubMed ID: 8178403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma.
    Margulis V; Tamboli P; Matin SF; Meisner M; Swanson DA; Wood CG
    J Urol; 2007 Nov; 178(5):1878-82. PubMed ID: 17868733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conservative surgical treatment of renal cell carcinoma. The University of Miami experience.
    Block NL; Ciancio G
    J Fla Med Assoc; 1995 Sep; 82(9):607-11. PubMed ID: 7595342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microscopic venous invasion in renal cell carcinoma as a predictor of recurrence after radical surgery.
    Ishimura T; Sakai I; Hara I; Eto H; Miyake H
    Int J Urol; 2004 May; 11(5):264-8. PubMed ID: 15147540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephron sparing surgery is a feasible and efficient treatment of T1a renal cell carcinoma in kidney transplant: a prospective series from a single center.
    Chambade D; Meria P; Tariel E; Vérine J; De Kerviler E; Peraldi MN; Glotz D; Desgrandchamps F; Mongiat-Artus P
    J Urol; 2008 Nov; 180(5):2106-9. PubMed ID: 18804233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laparoscopic versus open partial nephrectomy for the treatment of pathological T1N0M0 renal cell carcinoma: a 5-year survival rate.
    Permpongkosol S; Bagga HS; Romero FR; Sroka M; Jarrett TW; Kavoussi LR
    J Urol; 2006 Nov; 176(5):1984-8; discussion 1988-9. PubMed ID: 17070227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.